Published in:
05-05-2022 | Lymphoma | Correction
Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination
Published in: International Journal of Hematology | Issue 6/2022
Login to get accessExcerpt
In the original publication of the article, the table related to case study was missing. The case study table is given in this correction.|
Case
|
Disease
|
CD20 MoAb*1
|
SARS-CoV2
|
Anti-SARS-CoV-2 Antibodies (AU/mL)*2
|
Serum IgG (mg/dL)*3
|
Time*4
|
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Infection
|
Vaccine
|
IgG-N
|
IgM-N
|
IgG-S1
|
IgM-S1
|
Nab
|
|||||
|
Case 1
|
FL
|
37
|
+
|
−
|
n.t.*5
|
n.t
|
n.t
|
n.t
|
0.68
|
563
|
+ 2w
|
|
0.27
|
0.14
|
0.39
|
0.21
|
3.48
|
441
|
+ 4w
|
|||||
|
0.19
|
0.33
|
0.37
|
0.23
|
1.44
|
183
|
+ 10w
|
|||||
|
Case 2
|
FL
|
1
|
+
|
−
|
9.46
|
0.82
|
0.47
|
0.48
|
2.37
|
685
|
+ 2w
|
|
235.22
|
29.82
|
16.79
|
2.23
|
21.21
|
576
|
+ 4w
|
|||||
|
Case 3
|
FL
|
12
|
+
|
+
|
0.32
|
1.12
|
7.09
|
594.44
|
140.16
|
492
|
+ 2w
|
|
0.32
|
0.95
|
8.01
|
578.75
|
213.00
|
461
|
+ 4w
|
|||||
|
Case 4
|
Healthy
|
0
|
−
|
+
|
0.53
|
0.16
|
9.78
|
0.63
|
5.88
|
1,290
|
+ 2w
|
|
0.50
|
0.17
|
2145.96
|
18.97
|
2836.82
|
1,291
|
+ 4w
|
|||||